MIR3936HG

Across TCGA pan-cancer cohorts, MIR3936HG RNA is linked to patient survival in 29 of 34 cancer types, making it the most broadly survival-associated MIR3936HG data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher MIR3936HG RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated MIR3936HG expression acts as an unfavorable survival marker, although some lineages such as ACC and MESO show a favorable association.

ACC, MESO, and BRCA are the cancer types where MIR3936HG RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Median	All	0.634	0.287	<.001	125	view →
MESO	OS	Quartile	All	0.595	0.228	<.001	56	view →
BRCA	OS	Quartile	III,IV	0.980	0.841	<.001	41	view →
CESC	DFS	Quartile	All	0.788	0.946	<.001	40	view →
UCS	DFS	Tertile	IV	0.942	0.239	.024	24	view →
BLCA	DFS	Tertile	All	0.153	0.496	.009	23	view →
KIRP	DFS	Quartile	All	1.000	0.518	.005	22	view →
READ	OS	Quartile	All	1.000	0.303	.003	21	view →
UVM	OS	Tertile	II,III,IV	0.832	0.495	.008	19	view →
LUSC	DFS	Median	III,IV	0.423	0.651	.010	17	view →
HNSC	OS	Tertile	III,IV	0.549	0.774	.023	15	view →
CHOL	DFS	Tertile	All	0.798	0.130	.004	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 29 lineages.

MIR3936HG–ACC (DFS)

Open the ACC breakdown →